Jindal Saw Net Profit Drops 6% to Rs 479 Crore in Q3
By Rediff Money Desk, New Delhi Jan 24, 2025 16:08
Jindal Saw's net profit declined to Rs 479 crore in the December quarter, driven by lower income. The company's total income also decreased compared to the previous year.

Photograph: Wolfgang Rattay/Reuters
New Delhi, Jan 24 (PTI) Jindal Saw on Friday reported a decline of over 6 per cent in its net profit to Rs 479 crore in the December quarter, on account of lower income.
It had posted Rs 512 crore profit after tax in the year-ago period, the company said in an exchange filing.
Its total income came down to Rs 5,293 crore in the quarter under review from Rs 5,696 crore in the October-December period of the previous year.
The company is a leading global manufacturer and supplier of iron and steel pipe products, fittings and accessories.
It had posted Rs 512 crore profit after tax in the year-ago period, the company said in an exchange filing.
Its total income came down to Rs 5,293 crore in the quarter under review from Rs 5,696 crore in the October-December period of the previous year.
The company is a leading global manufacturer and supplier of iron and steel pipe products, fittings and accessories.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 9.47 (+ 2.05)
- 61048233
- Thinkink Picturez
- 0.45 ( 0.00)
- 22664084
- G G Engineering
- 1.22 ( -3.94)
- 18109205
- Srestha Finvest
- 0.69 ( -1.43)
- 12131937
- Hathway Cable & Data
- 14.75 ( -2.12)
- 11583833
MORE NEWS

J&K Leather Goods Industry: Vast...
Union minister highlights vast potential of J&K's leather goods industry....

Sebi Attaches Accounts of 10 in Eros Case - Rs...
Sebi has ordered the attachment of bank, demat, and mutual fund accounts of 10...

Innovation Crucial for Pharma Industry Growth:...
Piyush Goyal stresses the importance of innovation for the Indian pharmaceutical...